GO:1990647 C/EBP complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990647 (C/EBP complex) is a dimeric, sequence-specific DNA-binding transcription factor complex that regulates immune and inflammatory gene expression.
• The complex exists at least as C/EBPalpha and C/EBPbeta homodimers and binds the consensus site 5'-T[TG]NNGNAA[TG]-3'.
• C/EBPbeta recruits coactivator complexes such as Mediator and SWI/SNF to activate myeloid and inflammatory genes.
• CHOP inhibits C/EBP transcription factor activity by forming heterodimers with alternative DNA-binding specificity.
• C/EBP complexes cooperate with NFAT and Sp1/HMGI-Y in composite enhancer complexes controlling immune and metabolic genes.
• Dysregulated C/EBP complex activity contributes to acute lung injury, inflammation, and adipocyte differentiation programs.
Description
The C/EBP complex (GO:1990647) is a dimeric, sequence-specific DNA-binding transcription factor complex that regulates genes involved in immune and inflammatory responses. It exists at least as alpha and beta homodimeric forms and binds to regulatory regions of several acute-phase and cytokine genes, playing a role in the acute-phase reaction, inflammation, and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Transcription factor activity is inhibited by binding of CHOP, which forms heterodimers with alternative transcription factor activities. Researchers study this complex because it sits at the intersection of innate immunity, inflammation, and metabolism. C/EBPbeta recruits the Mediator complex and SWI/SNF chromatin remodelers to activate myeloid genes, and it cooperates with NFAT in composite enhancer complexes. In metabolic contexts, a nucleoprotein complex containing Sp1, C/EBPbeta, and HMGI-Y controls human insulin receptor gene transcription. These findings make GO:1990647 a key entity for understanding how sequence-specific transcription factors assemble on DNA to drive context-dependent gene programs. The C/EBP complex is also a paradigm for studying how dimer composition determines DNA-binding specificity and transcriptional output. Homodimers and heterodimers with CHOP or other bZIP partners can switch target gene sets, which is central to inflammation resolution and acute-phase responses. Because of its broad regulatory reach, the complex is a frequent focus of CRISPR-based functional genomics, reporter assays, and chromatin occupancy studies.
C/EBP complex At A Glance
| GO ID | GO:1990647 |
|---|---|
| GO term | C/EBP complex |
| Ontology | cellular_component |
| Synonym | C/EBPalpha complex; C/EBPalpha homodimer complex; C/EBPbeta complex; C/EBPbeta homodimer complex; C/EBP homodimer complex; C/EBP transcription factor complex |
| Major function | Dimeric, sequence-specific DNA-binding transcription factor complex regulating immune and inflammatory gene expression |
| DNA binding site | 5'-T[TG]NNGNAA[TG]-3' |
| Subunit composition | At least alpha and beta homodimeric forms; heterodimers with CHOP inhibit activity |
| Biological context | Acute-phase reaction, inflammation, hemopoiesis |
| Regulatory inhibition | CHOP heterodimerization switches DNA-binding specificity and inhibits transcription factor activity |
What Is GO:1990647?
GO:1990647 describes a dimeric, sequence-specific DNA-binding transcription factor complex that regulates genes involved in immune and inflammatory responses. It exists at least as alpha and beta homodimeric forms, binds to regulatory regions of several acute-phase and cytokine genes, and probably plays a role in the regulation of the acute-phase reaction, inflammation, and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Its transcription factor activity is inhibited by binding of CHOP, which forms heterodimers with alternative transcription factor activities.
Why Is C/EBP complex Important in Cell Biology?
The C/EBP complex is important because it converts extracellular inflammatory and metabolic signals into defined transcriptional programs. Its dimeric architecture allows combinatorial control: C/EBPbeta homodimers and heterodimers with CHOP or other bZIP factors can recognize different regulatory regions and recruit distinct coactivators. This flexibility is essential for acute-phase responses, cytokine gene regulation, and myeloid differentiation, and it explains why C/EBP complexes are recurrently implicated in inflammatory lung injury and metabolic gene control.
• Controls acute-phase and cytokine gene expression during inflammation.
• Regulates immune and inflammatory responses through sequence-specific DNA binding.
• Exists as alpha and beta homodimers with distinct target gene sets.
• Recruits Mediator and SWI/SNF coactivator complexes to activate myeloid genes.
• Cooperates with NFAT in composite enhancer complexes.
• Participates in adipocyte differentiation programs.
• Is inhibited by CHOP heterodimerization, altering DNA-binding specificity.
• Contributes to acute lung injury pathogenesis via C/EBPbeta- and C/EBPdelta-dependent transcription.
• Links inflammatory signaling to metabolic gene transcription such as the insulin receptor gene.
• Provides a model for studying dimer-dependent transcription factor specificity.
Structure and Composition of C/EBP complex
Dimeric bZIP architecture
In simple terms: The C/EBP complex is built from two protein subunits that pair up to grip DNA.
The C/EBP complex is a dimeric, sequence-specific DNA-binding transcription factor complex that exists at least as alpha and beta homodimeric forms. Dimerization is required for binding to the consensus recognition site 5'-T[TG]NNGNAA[TG]-3' in regulatory regions of acute-phase and cytokine genes. The dimeric arrangement allows each subunit to contribute to DNA recognition and to the recruitment of cofactors.
C/EBPalpha and C/EBPbeta homodimers
In simple terms: Different pairings of C/EBP proteins create complexes with different jobs.
C/EBPalpha and C/EBPbeta homodimers are the best-characterized forms of GO:1990647. C/EBPbeta is recruited to myeloid gene promoters where it nucleates coactivator assembly. C/EBPalpha homodimers are linked to adipocyte differentiation and metabolic gene regulation. The relative abundance of each homodimer influences which target genes are activated in a given cell type.
CHOP-containing heterodimers
In simple terms: CHOP pairs with C/EBP proteins and changes what the complex can do.
Transcription factor activity of the C/EBP complex is inhibited by binding of CHOP, which forms heterodimers with alternative transcription factor activities. These heterodimers alter DNA-binding specificity and can dampen C/EBPbeta- and C/EBPdelta-dependent transcription activation, as shown in models of LPS- and IgG immune complex-induced acute lung injury.
Composite enhancer complexes
In simple terms: C/EBP proteins often work together with other transcription factors on the same DNA element.
C/EBP complexes cooperate with NFAT in composite enhancer complexes, enabling integrated responses to immune signals. A nucleoprotein complex containing Sp1, C/EBPbeta, and HMGI-Y controls human insulin receptor gene transcription, illustrating how C/EBPbeta assembles with additional factors on metabolic gene promoters. These composite assemblies expand the regulatory repertoire beyond simple homodimer binding.
Coactivator recruitment
In simple terms: Once bound to DNA, the complex recruits machines that turn genes on.
C/EBPbeta recruits the Mediator complex and the SWI/SNF chromatin-remodeling complex to activate myeloid genes. Ras signaling induces mediator complex exchange on C/EBPbeta, demonstrating that coactivator composition is dynamically regulated. This coactivator recruitment step is a key determinant of transcriptional output from C/EBP-bound enhancers.
Key Genes Involved in GO:1990647 C/EBP complex
The following genes and proteins are core components or well-characterized interaction partners of the C/EBP complex (GO:1990647).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CEBPA | Encodes C/EBPalpha, forming alpha homodimers of the C/EBP complex | Adipocyte differentiation and metabolic gene regulation |
| CEBPB | Encodes C/EBPbeta, forming beta homodimers and recruiting coactivators | Myeloid gene activation and inflammatory transcription |
| CEBPD | Encodes C/EBPdelta, contributing to C/EBP-dependent transcription activation | Acute lung injury and inflammatory gene programs |
| CEBPG | Encodes C/EBPgamma, a negative regulator of C/EBPbeta-/C/EBPdelta-dependent activation | LPS-/IgG immune complex-induced acute lung injury |
| DDIT3 (CHOP) | Forms heterodimers with C/EBP proteins and inhibits their transcription factor activity | Inflammation and stress-responsive transcription |
| NFATC1 | Cooperates with C/EBP in composite enhancer complexes | Immune enhancer regulation |
| SP1 | Part of a nucleoprotein complex with C/EBPbeta and HMGI-Y | Insulin receptor gene transcription |
| HMGA1 (HMGI-Y) | Architectural factor in the Sp1/C/EBPbeta/HMGI-Y complex | Metabolic gene transcription |
| MED1 | Mediator subunit exchanged on C/EBPbeta upon Ras signaling | Coactivator dynamics on C/EBPbeta |
| SMARCA4 (BRG1) | SWI/SNF catalytic subunit recruited by C/EBPbeta | Myeloid gene activation |
| SMARCB1 (SNF5) | SWI/SNF subunit in C/EBPbeta-recruited remodeler complex | Chromatin remodeling at myeloid genes |
| RELA (NF-kB p65) | Forms a C/EBP-Rel complex in lymphoid cells | Composite immune transcription |
| AP-1 components | Coordinate with C/EBP in inflammatory transcription | IgG immune complex-induced acute lung injury |
| IL6 | Cytokine gene regulated by C/EBP complexes | Acute-phase and inflammatory responses |
| IL1B | Cytokine gene regulated by C/EBP complexes | Inflammatory gene expression |
| TNF | Cytokine gene regulated by C/EBP complexes | Inflammatory gene expression |
| INSR | Insulin receptor gene controlled by Sp1/C/EBPbeta/HMGI-Y complex | Metabolic gene transcription |
How Is C/EBP complex Regulated?
C/EBP complex activity is regulated at multiple levels. CHOP binding inhibits transcription factor activity by forming heterodimers with alternative DNA-binding specificity. C/EBPgamma acts as a critical negative regulator of LPS-/IgG immune complex-induced acute lung injury through downregulation of C/EBPbeta-/C/EBPdelta-dependent C/EBP transcription activation. cAMP signaling down-regulates C/EBP- and AP-1-mediated transcriptions and ameliorates IgG immune complex-induced acute lung injury. Ras signaling induces mediator complex exchange on C/EBPbeta, altering coactivator usage. These layers of regulation allow the complex to switch target gene programs in response to inflammatory and metabolic cues.
C/EBP complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CEBPB | Inflammatory acute lung injury | LPS-/IgG immune complex-induced acute lung injury model |
| CEBPG | Negative regulation of acute lung injury | Knockout or overexpression in lung injury models |
| DDIT3 (CHOP) | Inhibition of C/EBP transcription activity | Heterodimerization and reporter assays |
| CEBPA | Adipocyte differentiation and metabolic regulation | Adipocyte differentiation models |
| INSR | Insulin receptor gene transcription | Sp1/C/EBPbeta/HMGI-Y complex assays |
Acute lung injury and inflammation
C/EBP complexes are central to inflammatory lung injury. C/EBPgamma is a critical negative regulator of LPS-/IgG immune complex-induced acute lung injury through downregulation of C/EBPbeta-/C/EBPdelta-dependent C/EBP transcription activation. IgG immune complex-induced acute lung injury is ameliorated by cAMP via down-regulation of C/EBP- and AP-1-mediated transcriptions. These findings position GO:1990647 as a therapeutic node in acute inflammatory lung disease.
Metabolic and adipocyte biology
C/EBP complexes contribute to adipocyte differentiation and metabolic gene control. A nucleoprotein complex containing Sp1, C/EBPbeta, and HMGI-Y controls human insulin receptor gene transcription, linking C/EBPbeta to insulin sensitivity. Dysregulation of these complexes may therefore influence metabolic disorders.
Immune and lymphoid transcription
A C/EBP-Rel complex was identified in avian lymphoid cells, indicating that C/EBP proteins cooperate with NF-kB/Rel factors in immune cell contexts. NFAT.C/EBP composite enhancer complexes further demonstrate the role of C/EBP in immune gene regulation.
From C/EBP complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CEBPB loss reduce inflammatory gene activation? | CEBPB knockout cell line |
| Does CHOP heterodimerization inhibit C/EBP activity? | Point mutation disrupting CHOP-C/EBP interaction |
| Can a tagged C/EBPbeta track enhancer occupancy? | Tagged knock-in of CEBPB |
| Does C/EBPbeta overexpression drive myeloid gene programs? | CEBPB overexpression cell model |
| Which coactivators are required for C/EBP-dependent transcription? | CRISPR library screening for Mediator and SWI/SNF subunits |
| Does C/EBPgamma modulate C/EBPbeta-/C/EBPdelta-dependent activation? | CEBPG knockout or overexpression in immune cells |
How to Study the C/EBP complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide DNA occupancy of C/EBP proteins | Mapping C/EBP-bound enhancers and promoters |
| Luciferase reporter assay | Transcriptional activity from C/EBP-binding sites | Testing CHOP inhibition and enhancer function |
| Co-immunoprecipitation | Protein-protein interactions with C/EBP subunits | Identifying Mediator and SWI/SNF recruitment |
| RNA-seq | Changes in gene expression after perturbation | Defining C/EBP-dependent inflammatory programs |
| Western blot | Protein levels of C/EBP isoforms and partners | Validating knockout or overexpression models |
| EMSA | Sequence-specific DNA binding of C/EBP dimers | Confirming consensus site binding |
| Proteomics | Composition of C/EBP-containing complexes | Detecting coactivator exchange |
| CRISPR library screening | Fitness or reporter output after gene knockout | Identifying regulators of C/EBP-dependent transcription |
Chromatin immunoprecipitation and sequencing
ChIP-seq against C/EBPbeta or C/EBPalpha can map occupancy at the consensus site 5'-T[TG]NNGNAA[TG]-3' and identify composite enhancers shared with NFAT or Sp1. This method is essential for defining direct versus indirect target genes of GO:1990647.
Reporter and enhancer assays
Luciferase reporters driven by C/EBP-binding regulatory regions can quantify transcription factor activity and its inhibition by CHOP heterodimerization. Composite enhancer reporters can test cooperation with NFAT.
Co-immunoprecipitation and proteomics
Co-immunoprecipitation and mass spectrometry can identify coactivator complexes recruited by C/EBPbeta, including Mediator and SWI/SNF subunits. These approaches reveal dynamic coactivator exchange.
Transcriptomics after perturbation
RNA-seq after knockout or knockdown of CEBPB, CEBPG, or DDIT3 can define the gene programs controlled by the C/EBP complex in inflammatory and metabolic contexts.
How CRISPR Can Be Used to Study GO:1990647 C/EBP complex
Knockout
CRISPR knockout of CEBPB, CEBPA, CEBPD, or CEBPG can test which subunits are required for inflammatory gene activation and acute lung injury phenotypes. Knockout of DDIT3 (CHOP) can relieve inhibition of C/EBP transcription factor activity.
Point Mutation
Point mutations can disrupt dimerization interfaces or DNA-contacting residues to separate DNA binding from coactivator recruitment. Such mutants help define how the consensus site 5'-T[TG]NNGNAA[TG]-3' is recognized.
Knock-in
Tagged knock-in of CEBPB or CEBPA enables endogenous ChIP-seq, imaging, and proteomics without overexpression artifacts. Knock-in of reporter alleles can monitor C/EBP-dependent transcription in real time.
Overexpression
Overexpression of C/EBPbeta or C/EBPalpha can drive myeloid or adipocyte gene programs and test sufficiency. Overexpression of C/EBPgamma can suppress C/EBPbeta-/C/EBPdelta-dependent activation.
How EDITGENE Supports C/EBP complex Research
Researchers studying C/EBP complex-related genes often need to determine whether a candidate gene is causally involved in inflammatory or metabolic transcription, and CRISPR-based models provide the most direct way to establish causality. EDITGENE supports this work with validated knockout, point-mutation, knock-in, and overexpression cell models, together with CRISPR library screening and bioinformatics services.
Contact EDITGENE today to design your custom CRISPR model for C/EBP complex research.
Frequently Asked Questions About C/EBP complex
What is the C/EBP complex?
The C/EBP complex (GO:1990647) is a dimeric, sequence-specific DNA-binding transcription factor complex that regulates genes involved in immune and inflammatory responses.
What genes are involved in the C/EBP complex?
Core genes include CEBPA, CEBPB, CEBPD, CEBPG, and DDIT3 (CHOP), along with cooperating factors such as NFATC1, SP1, and HMGA1.
What DNA sequence does the C/EBP complex bind?
It binds the consensus recognition site 5'-T[TG]NNGNAA[TG]-3' in regulatory regions of acute-phase and cytokine genes.
How is C/EBP complex activity inhibited?
Transcription factor activity is inhibited by binding of CHOP, which forms heterodimers with alternative transcription factor activities.
What diseases are linked to the C/EBP complex?
It is linked to acute lung injury and inflammation, and to metabolic gene regulation such as insulin receptor transcription.
What coactivators does C/EBPbeta recruit?
C/EBPbeta recruits the Mediator complex and the SWI/SNF chromatin-remodeling complex to activate myeloid genes.
Does the C/EBP complex cooperate with NFAT?
Yes, transcription cooperation by NFAT.C/EBP composite enhancer complexes has been demonstrated.
What is the role of C/EBPgamma?
C/EBPgamma is a critical negative regulator of LPS-/IgG immune complex-induced acute lung injury through downregulation of C/EBPbeta-/C/EBPdelta-dependent transcription activation.
How can I study the C/EBP complex with CRISPR?
Knockout, point mutation, knock-in, and overexpression models can test subunit function, DNA binding, and coactivator recruitment.
Is the C/EBP complex involved in metabolism?
Yes, a nucleoprotein complex containing Sp1, C/EBPbeta, and HMGI-Y controls human insulin receptor gene transcription.
Conclusion
GO:1990647 (C/EBP complex) is a dimeric, sequence-specific transcription factor complex that converts inflammatory and metabolic signals into defined gene programs. Its alpha and beta homodimers, CHOP-containing heterodimers, and composite enhancer assemblies with NFAT, Sp1, and HMGI-Y make it a versatile regulator of immunity, acute-phase responses, and metabolism. Because C/EBP complexes are causally implicated in acute lung injury and metabolic gene control, they are attractive targets for CRISPR-based functional studies. Knockout, point-mutation, knock-in, and overexpression models, combined with CRISPR library screening and bioinformatics, provide a rigorous path to define how each subunit and partner contributes to C/EBP-dependent transcription.
References
- 1. Gregoire FM et al.. 1998. Understanding adipocyte differentiation.. Physiol Rev 78(3):783-809 PMID: 9674695
- 2. Yang TT et al.. 2003. Transcription cooperation by NFAT.C/EBP composite enhancer complex.. J Biol Chem 278(18):15874-85 PMID: 12606546
- 3. Yan C et al.. 2020. C/EBPγ is a critical negative regulator of LPS-/IgG immune complex-induced acute lung injury through the downregulation of C/EBPβ-/C/EBPδ-dependent C/EBP transcription activation.. FASEB J 34(10):13696-13710 PMID: 32786052
- 4. Mo X et al.. 2004. Ras induces mediator complex exchange on C/EBP beta.. Mol Cell 13(2):241-50 PMID: 14759369
- 5. Kowenz-Leutz E et al.. 1999. A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes.. Mol Cell 4(5):735-43 PMID: 10619021
- 6. Diehl JA et al.. 1994. Identification of a C/EBP-Rel complex in avian lymphoid cells.. Mol Cell Biol 14(10):6635-46 PMID: 7935382
- 7. Yan C et al.. 2023. IgG immune complex-induced acute lung injury is ameliorated by cAMP via down-regulation of C/EBP- and AP-1-mediated transcriptions.. J Inflamm (Lond) 20(1):34 PMID: 37864223
- 8. Foti D et al.. 2003. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription.. Mol Cell Biol 23(8):2720-32 PMID: 12665574
